DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.
Nearly 10% of postmarket device safety reports in MAUDE were submitted over 6 months after the safety event occurred.
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Investor's Business Daily on MSN3d
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedDexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
The recent selloff of U.S. equities continued at midday on fears the U.S. economy could be heading toward a recession. The Nasdaq sank 3%, the S&P 500 dipped about 2%, and the Dow Jones Industrial ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback